This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50931012
rdf:type
wikibase:Item
schema:description
научная статья мақолаи илмӣ 2006年学术文章 artigo científico наукова стаття, опублікована в липні 2006 articol științific научни чланак bilimsel makale wissenschaftlicher Artikel artikel ilmiah vedecký článok artykuł naukowy บทความทางวิทยาศาสตร์ artigo científico 2006年学术文章 2006年学术文章 vitskapeleg artikkel bài báo khoa học научни чланак tieteellinen artikkeli სამეცნიერო სტატია artikull shkencor 2006年の論文 artículu científicu vetenskaplig artikel 2006年學術文章 vědecký článek artigo científico জুলাই ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ επιστημονικό άρθρο 2006年学术文章 scienca artikolo 2006年學術文章 wetenschappelijk artikel articolo scientifico 2006年学术文章 scientific article published in July 2006 مقالة علمية نشرت في يوليو 2006 2006년 논문 artikulong pang-agham научна статия article scientifique 2006年學術文章 artículo científico publicado en 2006 article científic naučni članak scientific article published in July 2006 2006年學術文章 article scientific מאמר מדעי 2006 nî lūn-bûn 2006年學術文章 vitenskapelig artikkel videnskabelig artikel tudományos cikk 2006年学术文章 teaduslik artikkel scientific article published in July 2006
p:P577
wds:Q50931012-C14E49C2-B6DA-42C3-BA11-66E2252EAA20
wdt:P577
2006-07-01T00:00:00Z
p:P2860
wds:Q50931012-F2F1BA72-8AE8-4B9B-A3B7-DBB734797E27 wds:Q50931012-686BA69E-0EB0-455C-8629-2FF91D791CFB wds:Q50931012-735B0251-AC2F-4110-8A18-B2398A28AFD1 wds:Q50931012-54575A1B-42DB-45D3-93BF-1ECA3F4D92A6 wds:Q50931012-58A636D7-A7E3-4EEA-8E32-5F84CA40B29F wds:Q50931012-A4D8C359-942F-4AC3-B44E-F8222AABAA6A wds:Q50931012-943BCFC9-F913-4FB9-BD67-1F52675E5E47 wds:Q50931012-96E40025-1D92-413E-99DC-B892146C2747 wds:Q50931012-A2BB9D8F-FB91-4CB7-8073-236FDBFAB8FE wds:Q50931012-12062A7A-875A-47BD-8F6B-CB4604DA92F0 wds:Q50931012-18A9C2A1-8192-435A-8A23-550B9BE57798 wds:Q50931012-1BC9F030-EA0B-4D92-B0FC-F6C6C86A9414 wds:Q50931012-056C9362-F772-4933-B1AF-6848DCD605BD wds:Q50931012-08872FDC-03F3-40BB-8B06-F8E4B676B549 wds:Q50931012-089305D7-A8D8-43A0-BD85-2041454E133F wds:Q50931012-311CF19A-D0CE-495D-94E0-75DAF491FA1B wds:Q50931012-3EC1656F-A137-42B9-9633-DFD6EDD41AA5 wds:Q50931012-485E7209-C201-460E-BA76-2ADDE56F0148 wds:Q50931012-2AF46C2A-5A2E-4B71-BDCB-F3B59063495F wds:Q50931012-2DB35A2E-F79A-414C-ADF2-A82C83CCA01E wds:Q50931012-2DF60A9D-0F4D-46E5-BAEC-67FE42D77C5D
wdt:P2860
wd:Q56157637 wd:Q28258215 wd:Q44097675 wd:Q28214486 wd:Q33897377 wd:Q72037135 wd:Q34086053 wd:Q53344714 wd:Q47354835 wd:Q60647025 wd:Q48732957 wd:Q77374064 wd:Q37417940 wd:Q42549344 wd:Q29614719 wd:Q24564540 wd:Q74054728 wd:Q72824734 wd:Q56080490 wd:Q41595625 wd:Q55051636
p:P2093
wds:Q50931012-3905163A-506F-4FA6-95FB-85953AC96D11 wds:Q50931012-55BD58B2-195E-47E3-AC09-8955BD691E8E wds:Q50931012-5F0A44D5-F699-4DB6-999F-575B382AAE9F wds:Q50931012-B4110E84-1F3E-4370-8EF2-F91D1ABF7A84 wds:Q50931012-B2859A2D-C02B-4632-9F47-2DCFD91FA489
wdt:P2093
Salih Saygin Eker Selcuk Kirli Enver Yusuf Sivrioglu Cengiz Akkaya Semra Akgoz
rdfs:label
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
skos:prefLabel
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
schema:name
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
p:P1476
wds:Q50931012-83E77542-7856-4BDF-A9AC-BA68BE497CD4
wdt:P1476
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
p:P304
wds:Q50931012-51C32DA9-5830-401F-A750-31FEF4455CFB
wdt:P304
337-345
p:P31
wds:Q50931012-CD6AE59E-E9BC-40B9-9A4E-345E897CC93A
wdt:P31
wd:Q13442814
p:P698
wds:Q50931012-B7BDCA83-2CE1-4D72-86E2-A37E74ADECB2
wdtn:P698
n4:16856215
wdt:P698
16856215
p:P1433
wds:Q50931012-2B3A2E9C-DF6B-46C3-A5D5-7EB6F507AF8A
wdt:P1433
wd:Q15751477
p:P433
wds:Q50931012-59BEA536-9624-400F-A4B5-CBD20BE173B0
p:P478
wds:Q50931012-FDEAF921-6E54-432D-9A74-E0E0DDA68B78
wdt:P433
5
wdt:P478
21
p:P356
wds:Q50931012-18757D06-1557-4D32-AE7D-A944DFAA5D57
wdtn:P356
n11:HUP.770
wdt:P356
10.1002/HUP.770